Phase 1 Study of the Safety and Pharmacokinetics of YN001 With Rosuvastatin in Healthy Chinese Subjects
The primary objective of this study is to investigate the safety and tolerability of YN001 in combination with rosuvastatin, so as to provide evidence for the feasibility of YN001 combined with statins in subsequent clinical trials.
Fully understand the purpose, characteristics, research methods and potential ad... [+5]
Participation in other clinical trials within 3 months prior to the first dose o... [+25]